Goran U. Carlsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancer.
Journal: Cancer treatment and research communications
Published: July 21, 2025
HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR).
Journal: British journal of haematology
Published: February 16, 2023
Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancer.
Journal: World journal of surgical oncology
Published: June 10, 2022
A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer.
Journal: ESMO open
Published: May 19, 2022
Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia.
Journal: Blood
Published: July 07, 2021
Kostmann disease and other forms of severe congenital neutropenia.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: April 08, 2021
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin.
Journal: Cancer chemotherapy and pharmacology
Published: July 14, 2020
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells.
Journal: British journal of haematology
Published: June 15, 2020
Folate pathway genes linked to mitochondrial biogenesis and respiration are associated with outcome of patients with stage III colorectal cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 22, 2019
Last Updated: 09/26/2026